MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm	Recruiting	Phase 1 / Phase 2	2026-06-10		NCT05655312

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Perspective Therapeutics	5

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fox Chase Cancer Center	Philadelphia	United States	259
Mayo Clinic	Jacksonville	United States	122
Mayo Clinic Rochester	Rochester	United States	133
Nebraska Cancer Specialists	Omaha	United States	40
Saint Louis University Hospital	St Louis	United States	3
Sarasota Memorial Hospital	Sarasota	United States	56
University of California Irvine	Orange	United States	49
University of Iowa	Iowa City	United States	284
University of Kentucky	Lexington	United States	98
University of Miami	Miami	United States	327
University of Wisconsin Carbone Cancer Center	Madison	United States	58
UPMC Hillman Cancer Center	Pittsburgh	United States	330
Washington University of St. Louis	St Louis	United States	4